Clinical trial
Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer
NCT00438100
Study timeline
Study start (unknown)2008-04-01Date precision: month
Registry last updated2015-05-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Neoplasmsunresolved
Interventions
CapecitabineDRUG · verified · RxNorm: capecitabine
S-1DRUG
Sponsors & collaborators
Japan Breast Cancer Research Networklead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00438100 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.